Results 201 to 210 of about 29,969,840 (342)
The pan‐HDAC inhibitor belinostat increases the expression of the pro‐apoptotic proteins Bim, Puma, and Noxa and induces apoptosis in ovarian cancer cell lines and patient‐derived tumor organoids when used at high concentrations. Moreover, inhibiting the anti‐apoptotic proteins Bcl‐xL or Mcl‐1 sensitizes these preclinical models to the cytotoxic effect
Cécilia Thomine+10 more
wiley +1 more source
Feasibility of data extraction and evaluation with BeoNet-Halle: outcomes and data quality in hepatitis B and C screenings. [PDF]
Moser K, Bauch F, Brütting C, Frese T.
europepmc +1 more source
Systematic profiling of cancer‐fibroblast interactions reveals drug combinations in ovarian cancer
Fibroblasts, cells in the tumor environment, support ovarian cancer cell growth and alter morphology and drug response. We used fibroblast and cancer cell co‐culture models to test 528 drugs and discovered new drugs for combination treatment. We showed that adding Vorinostat or Birinapant to standard chemotherapy may improve drug response, suggesting ...
Greta Gudoityte+10 more
wiley +1 more source
Protocol for achieving enhanced snRNA-seq data quality using Quality Clustering. [PDF]
Tavi PJ+3 more
europepmc +1 more source
The Characterization of Ozone and Sulfur Dioxide Air Quality Data for Assessing Possible Vegetation Effects [PDF]
Allen S. Lefohn, Cindy K. Jones
openalex +1 more source
The COMBAT classification system, developed through multi‐omics integration, stratifies adult patients with B‐cell acute lymphoblastic leukemia(B‐ALL) into three molecular subtypes with distinct surface antigen patterns, immune landscape, methylation patterns, biological pathways and prognosis.
Yang Song+11 more
wiley +1 more source
Correction: Examining trip-level errors in passively collected mobile device data for data quality assurance. [PDF]
PLOS One Staff.
europepmc +1 more source
Nonparametric tests for trends in water-quality data using the statistical analysis system [PDF]
Charles G. Crawford+2 more
openalex +1 more source
In patients treated with atezolizumab as a part of the MyPathway (NCT02091141) trial, pre‐treatment ctDNA tumor fraction at high levels was associated with poor outcomes (radiographic response, progression‐free survival, and overall survival) but better sensitivity for blood tumor mutational burden (bTMB).
Charles Swanton+17 more
wiley +1 more source
Child immunization data quality in Rwanda: an assessment of routine health information system data. [PDF]
Uwera T+7 more
europepmc +1 more source